Long-term outcomes and prognostic factors of skull-base chondrosarcoma patients treated with pencil-beam scanning proton therapy at the Paul Scherrer Institute.

@article{Weber2016LongtermOA,
  title={Long-term outcomes and prognostic factors of skull-base chondrosarcoma patients treated with pencil-beam scanning proton therapy at the Paul Scherrer Institute.},
  author={Damien Charles Weber and Shahed N. Badiyan and Robert S. Malyapa and Francesca Yardenit Albertini and Alessandra Bolsi and Antony John Lomax and Ralf A. Schneider},
  journal={Neuro-oncology},
  year={2016},
  volume={18 2},
  pages={
          236-43
        }
}
BACKGROUND Skull-base chondrosarcoma (ChSa) is a rare disease, and the prognostication of this disease entity is ill defined. METHODS We assessed the long-term local control (LC) results, overall survival (OS), and prognostic factors of skull-base ChSa patients treated with pencil beam scanning proton therapy (PBS PT). Seventy-seven (male, 35; 46%) patients with histologically confirmed ChSa were treated at the Paul Scherrer Institute. Median age was 38.9 years (range, 10.2-70.0y). Median… CONTINUE READING
1
Twitter Mention

Citations

Publications citing this paper.
SHOWING 1-10 OF 16 CITATIONS

Proton therapy for tumors of the base of the skull.

VIEW 19 EXCERPTS
CITES BACKGROUND
HIGHLY INFLUENCED

Long term outcome of skull-base chondrosarcoma patients treated with high-dose proton therapy with or without conventional radiation therapy.

VIEW 4 EXCERPTS
CITES METHODS & BACKGROUND

Skull base chordoma treated with proton therapy: A systematic review

VIEW 1 EXCERPT
CITES BACKGROUND

Current questions in bone sarcomas

VIEW 1 EXCERPT
CITES BACKGROUND

References

Publications referenced by this paper.
SHOWING 1-10 OF 23 REFERENCES

Cranial chondrosarcoma and recurrence.

VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL